Gene therapy.
Verma
I M
IM
Salk Institute, La Jolla, Calif.
D000243:Adenosine Deaminase / Q000172:deficiency / Q000235:genetics; D000818:Animals; D001854:Bone Marrow Cells; D002648:Child; D005260:Female; D005818:Genetic Engineering; D015316:Genetic Therapy; D005822:Genetic Vectors; D005914:Globins / Q000235:genetics; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000201:enzymology / Q000628:therapy; D008099:Liver / Q000166:cytology; D008214:Lymphocytes; D008297:Male; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000628:therapy; D011817:Rabbits; D012190:Retroviridae / Q000235:genetics / Q000502:physiology; D013789:Thalassemia / Q000628:therapy; D014162:Transfection; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics; D014481:United States
D014409:Tumor Necrosis Factor-alpha; D005914:Globins; D000243:Adenosine Deaminase